Ansell Limited (ANSLY)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Ansell Limited (ANSLY) trades at $81.94 with AI Score 56/100 (Grade B). Ansell Limited is a global leader in protection solutions, specializing in the design and manufacture of surgical, examination, and industrial gloves, alongside chemical protective clothing. Market cap: $2.89B, Sector: Healthcare.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for ANSLY: ANSLY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ANSLY against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
ANSLY: 4/6 perspectives are bullish. Dominant signal: Ray Dalio bullish.
How is this calculated? →Ansell Limited (ANSLY) Healthcare & Pipeline Overview
Ansell Limited, founded in 1893 and headquartered in Richmond, Australia, is a global leader in protection solutions, specializing in the design, development, and manufacture of surgical, examination, and industrial gloves, alongside chemical protective clothing. Operating across Healthcare and Industrial segments, the company serves diverse markets from hospitals to heavy industries globally.
What Is the Investment Thesis for ANSLY?
Ansell Limited (ANSLY) presents a compelling investment profile rooted in its established market position within the essential protection solutions industry and its diversified operational segments. With a market capitalization of $2.89B and a P/E ratio of 20.8, the company demonstrates profitability with a 6.7% profit margin and a robust 41.9% gross margin. The dividend yield of 2.75% offers income potential, while a Beta of 0.55 indicates lower volatility compared to the broader market. Key growth catalysts include the consistent global demand for healthcare-related PPE driven by an aging population and increased surgical procedures, coupled with stringent industrial safety regulations across various sectors. The company's extensive global distribution network and strong brand recognition provide a competitive advantage. However, as an ADR trading on the OTC Other tier, investors may want to evaluate potential risks associated with lower liquidity and varying reporting standards. Monitoring global economic conditions and raw material costs is crucial, as these factors can significantly impact Ansell's profitability and operational efficiency.
Based on FMP financials and quantitative analysis
ANSLY Key Highlights
- Market Capitalization of $2.89B reflects a significant presence in the global protection solutions market.
- A P/E ratio of 20.8 indicates the market's valuation of its earnings, positioning it within the broader industry context.
- Profit Margin of 6.7% demonstrates the company's ability to convert revenue into net income efficiently.
- Gross Margin of 41.9% highlights strong profitability at the product level, indicating effective cost management and pricing power.
- A Dividend Yield of 2.75% provides a return to shareholders, underscoring a commitment to shareholder value.
Who Are ANSLY's Competitors?
ANSLY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| RGEDF Gedeon Richter PLC | $39.76 | +0.30% | $7.27B | 53 |
| NYXH Nyxoah S.A. | $1.75 | +1.74% | $69.31M | 69 |
| KMTS Kestra Medical Technologies, Ltd. | $27.70 | +2.67% | $1.62B | 67 |
| ZTEK Zentek Ltd. | $0.46 | +2.88% | $49.90M | 63 |
| OMIC Singular Genomics Systems, Inc. | $20.01 | +0.00% | $50.77M | 61 |
| ISRG Intuitive Surgical, Inc. | $432.83 | +1.60% | $153.29B | 56 |
| TDVXF Tobii Dynavox AB (publ) | $6.45 | +12.17% | $684.12M | 56 |
| HOCPY HOYA Corporation | $158.60 | +0.48% | $53.05B | 56 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ANSLY's Key Strengths?
- Long-standing global brand reputation and market leadership in protection solutions.
- Diversified revenue streams from two robust segments: Healthcare and Industrial.
- Extensive global presence across Asia Pacific, Europe, Middle East, Africa, Latin America, and North America.
- Strong gross margin of 41.9% indicating efficient production and pricing power.
What Are ANSLY's Weaknesses?
- Exposure to fluctuations in raw material costs, which can impact profitability.
- As an ADR on the OTC Other tier, it may face lower liquidity compared to major exchange listings.
- Dependence on global economic conditions affecting industrial output and healthcare spending.
- Potential for increased competition from local manufacturers in diverse global markets.
What Could Drive ANSLY Stock Higher?
- Continued global expansion of healthcare infrastructure and services, driving demand for medical PPE.
- Implementation of stricter industrial safety regulations worldwide, increasing the need for specialized protective clothing.
- Successful introduction of innovative products leveraging advanced materials or smart technology, enhancing market share.
- Strategic acquisitions or partnerships that expand product lines or geographic reach, contributing to revenue growth.
- Favorable shifts in raw material costs, leading to improved profit margins and operational efficiency.
What Are the Key Risks for ANSLY?
- Fluctuations in raw material costs, particularly for polymers and chemicals, could compress profit margins.
- Intense competition from both established global players and local manufacturers in diverse markets.
- Adverse currency exchange rate movements, especially between AUD and USD, impacting reported financial performance for ADR holders.
- Global economic downturns or recessions could reduce industrial activity and healthcare spending, affecting demand.
- Supply chain disruptions due to geopolitical events, natural disasters, or trade protectionism, impacting production and distribution.
What Are the Growth Opportunities for ANSLY?
- **Expanding Global Healthcare Demand**: The healthcare segment is poised for sustained growth due to an aging global population, increasing prevalence of chronic diseases requiring medical intervention, and a heightened focus on infection control. Ansell's comprehensive range of surgical, examination, and sterile gloves and garments directly addresses these needs. The global medical gloves market, for instance, is projected to continue its expansion, driven by rising healthcare expenditure and increased surgical volumes, providing a substantial and ongoing market for Ansell's core products over the next decade.
- **Stricter Industrial Safety Regulations**: Governments and international bodies are continuously implementing more stringent occupational safety and health regulations across various industrial sectors. This regulatory push mandates the use of high-quality protective clothing and hand protection in industries such as chemical, automotive, and oil & gas. Ansell's specialized industrial segment is well-positioned to benefit from this trend, offering advanced chemical protective clothing and durable gloves that meet evolving safety standards, ensuring consistent demand for its solutions in the long term.
- **Penetration into Emerging Markets**: Significant growth opportunities exist in emerging economies across Asia Pacific, Latin America, and Africa. As these regions experience rapid industrialization, economic development, and improvements in healthcare infrastructure, the demand for reliable protection solutions is expected to surge. Ansell's established global presence allows it to strategically expand its distribution channels and market penetration in these high-growth areas, tapping into new customer bases and increasing its overall market share over the next five to ten years.
- **Product Innovation and Advanced Materials**: Continuous innovation in material science and product design offers a key growth avenue. Developing next-generation protective solutions with enhanced comfort, dexterity, durability, and sustainability features can differentiate Ansell from competitors. Investments in R&D for smart PPE, biodegradable materials, or specialized coatings that offer superior protection against new threats can open up premium market segments and sustain competitive advantage, driving growth over the medium to long term.
- **Strategic Acquisitions and Partnerships**: Inorganic growth through targeted acquisitions or strategic partnerships can significantly expand Ansell's product portfolio, technological capabilities, or geographic reach. Identifying and integrating smaller, innovative companies specializing in niche protection solutions or advanced manufacturing techniques could enhance Ansell's market position and create synergies. This strategy allows for rapid market entry into new segments or regions, contributing to accelerated growth and diversification of revenue streams within the next three to five years.
What Opportunities Does ANSLY Have?
- Growing demand for PPE driven by increased health awareness and stricter safety regulations worldwide.
- Expansion into emerging markets with rising industrialization and improving healthcare infrastructure.
- Product innovation in advanced materials and smart PPE to capture premium market segments.
- Strategic acquisitions to expand product portfolio or geographic footprint.
- Leveraging sustainability trends by developing eco-friendly protection solutions.
What Threats Does ANSLY Face?
- Intense competition from both established players and new entrants in the PPE market.
- Supply chain disruptions, geopolitical events, or trade barriers impacting global operations.
- Currency exchange rate fluctuations affecting reported earnings for ADR holders.
- Regulatory changes in healthcare or industrial safety that could increase compliance costs.
- Economic downturns reducing industrial activity and discretionary healthcare spending.
What Are ANSLY's Competitive Advantages?
- Established global brand reputation built over a century in protection solutions.
- Extensive product portfolio catering to diverse and critical healthcare and industrial needs.
- Global distribution network spanning multiple continents, ensuring broad market reach.
- Strong relationships with institutional buyers in healthcare and large industrial clients.
- Expertise in material science and manufacturing processes for specialized protective equipment.
What Does ANSLY Do?
Ansell Limited, a company with a rich history dating back to its founding in 1893, has evolved into a prominent global designer, developer, and manufacturer of advanced protection solutions. Originally known as Pacific Dunlop Limited, the company rebranded to Ansell Limited in 2002, solidifying its focus on safety and protection. Headquartered in Richmond, Australia, Ansell operates through two primary segments: Healthcare and Industrial, demonstrating a diversified approach to the personal protective equipment (PPE) market. The Healthcare segment is dedicated to producing and marketing a comprehensive range of solutions vital for medical and life sciences professionals. This includes surgical gloves, single-use and examination gloves, and specialized clean and sterile gloves and garments. These products are critical for maintaining aseptic environments and protecting personnel in hospitals, surgical centers, dental practices, veterinary clinics, and laboratories, as well as for first responders and pharmaceutical companies. The Industrial segment focuses on manufacturing and marketing hand and chemical protective clothing solutions tailored for a vast array of industrial applications. Its products are essential for worker safety in demanding sectors such as automotive, chemical processing, metal fabrication, machinery and equipment, food processing, construction, mining, oil and gas, and for first responders. Ansell's extensive geographic footprint spans the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America, underscoring its global market presence. With P. D. Holdings Pty. Ltd. operating as a current subsidiary, Ansell Limited continues to leverage its established brand reputation and extensive product portfolio to address the evolving protection needs of a global clientele.
What Products and Services Does ANSLY Offer?
- Designs and develops protection solutions for various industries and healthcare.
- Manufactures surgical gloves, single-use, and examination gloves for medical use.
- Produces clean and sterile gloves and garments for hospitals and laboratories.
- Creates hand and chemical protective clothing for industrial applications.
- Serves hospitals, surgical centers, dental practices, and veterinary clinics.
- Supplies first responders, laboratories, and life sciences companies.
- Provides solutions for automotive, chemical, metal fabrication, and food industries.
- Offers protective gear for construction, mining, oil and gas sectors.
How Does ANSLY Make Money?
- Designs, manufactures, and markets a diversified portfolio of protection solutions.
- Operates through two primary segments: Healthcare and Industrial, catering to distinct customer needs.
- Generates revenue from direct sales and distribution networks across multiple continents.
- Focuses on providing essential, high-quality personal protective equipment (PPE) for safety and hygiene.
- Leverages a global supply chain and established brand reputation to maintain market presence.
What Industry Does ANSLY Operate In?
Ansell Limited operates within the critical and growing Medical - Instruments & Supplies industry, specifically focusing on personal protective equipment (PPE) for both healthcare and industrial sectors. The global PPE market is characterized by increasing demand driven by heightened health and safety awareness, stricter regulatory frameworks, and ongoing industrialization in emerging economies. Ansell's dual segment structure positions it to capitalize on growth in both the healthcare sector, fueled by demographic shifts and medical advancements, and the industrial sector, propelled by manufacturing expansion and occupational safety mandates. The competitive landscape includes specialized PPE manufacturers and broader medical device companies. Ansell differentiates itself through its long-standing brand reputation, extensive product portfolio, and global distribution network, allowing it to maintain a significant share in a fragmented yet essential market.
Who Are ANSLY's Key Customers?
- Hospitals, surgical centers, dental practices, and veterinary clinics.
- First responders, laboratories, and life sciences companies.
- Pharmaceutical companies requiring clean and sterile environments.
- Industrial sectors including automotive, chemical, and metal fabrication.
- Food processing, construction, mining, and oil & gas industries.
Ansell Limited (ANSLY) Valuation Context
Valued at $2.89B, ANSLY is classified as a mid-cap stock. Relative to its peer group, ANSLY's quantitative score of 56/100 is roughly in line with the peer average of 63/100.
ANSLY Revenue & Earnings Trend
In Q4 2025, ANSLY generated $1.03B in top-line revenue, marking a sequential increase of 4.5%. The company recorded net income of $89.0M, with diluted EPS of $2.44. Quarter-over-quarter revenue has been mixed, typical for a mid-cap company operating in Healthcare. Across the four most recent quarters, ANSLY averaged $1.52 in diluted EPS.
Company Profile
Ansell Limited operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Richmond, AU. The company is led by CEO Nathalie Ahlstrom. ANSLY has traded publicly since 2013.
ROE 7%Key Financial Metrics
Return on equity for Ansell Limited stands at 7.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.2%, showing how much profit it generates from its asset base. ANSLY trades at a trailing price-to-earnings ratio of 20.81, roughly in line with the Healthcare sector average of ~23x. Its free cash flow yield is 6.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.36 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 4.8%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 6/9Financial Health
Ansell Limited's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 3.63 places it in the safe zone, indicating low near-term bankruptcy risk.
FY2026 estForward Outlook
Wall Street analysts project Ansell Limited revenue of about $2.08B for fiscal 2026, with EPS near $5.80. The estimate reflects 11 contributing analysts.
ANSLY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Long-standing global brand reputation and market leadership in protection solutions.
- Diversified revenue streams from two robust segments: Healthcare and Industrial.
- Extensive global presence across Asia Pacific, Europe, Middle East, Africa, Latin America, and North America.
- Strong gross margin of 41.9% indicating efficient production and pricing power.
Bear Case
- Exposure to fluctuations in raw material costs, which can impact profitability.
- As an ADR on the OTC Other tier, it may face lower liquidity compared to major exchange listings.
- Dependence on global economic conditions affecting industrial output and healthcare spending.
- Potential for increased competition from local manufacturers in diverse global markets.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $1.03B | $89M | $2.44 |
| Q2 2025 | $984M | $47M | $1.28 |
| Q4 2024 | $1.02B | $55M | $1.52 |
| Q2 2024 | $831M | $57M | $0.84 |
Based on FMP financials and quantitative analysis
ANSLY Latest News
-
Ansell Announces Greenovation(TM) Awards for Sustainability Leadership and Waste Reduction
Yahoo! Finance: ANSLY News · May 29, 2026
ANSLY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ANSLY.
Price Targets
Wall Street price target analysis for ANSLY.
ANSLY MoonshotScore
What does this score mean?
The MoonshotScore rates ANSLY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Nathalie Ahlstrom
Chief Executive Officer
Unknown. Specific details regarding Nathalie Ahlstrom's career history, educational background, previous roles, and professional credentials are not available in the provided source data. Therefore, a comprehensive biographical profile cannot be constructed based on the given information.
Track Record: Unknown. Key achievements, strategic decisions, or company milestones directly attributable to Nathalie Ahlstrom's leadership at Ansell Limited are not detailed in the provided source material. Consequently, a specific track record cannot be outlined at this time.
Ansell Limited ADR Information Unsponsored
An American Depositary Receipt (ADR) is a certificate issued by a U.S. bank representing shares in a foreign stock. For ANSLY, it allows U.S. investors to trade shares of Ansell Limited, an Australian company, on U.S. markets without directly trading on the Australian exchange. This simplifies cross-border investing by handling currency conversion and share custody, making it accessible to a broader investor base.
- Home Market Ticker: The primary stock exchange for Ansell Limited is the Australian Securities Exchange (ASX), and its home country is Australia.
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: ANSL
ANSLY OTC Market Information
ANSLY trades on the OTC Other tier of the OTC market, which is distinct from major exchanges like the NYSE or NASDAQ. The OTC Other tier, also known as the Pink Sheets, represents the lowest tier for OTC securities and typically includes companies that do not meet the minimum disclosure requirements of OTCQX or OTCQB, or choose not to provide financial information to OTC Markets Group. Unlike major exchanges with strict listing standards for market capitalization, public float, and financial reporting, OTC Other has minimal requirements. This can lead to less transparency and higher risk for investors compared to exchange-listed stocks.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Lower liquidity and wider bid-ask spreads compared to exchange-listed securities.
- Potentially less stringent financial reporting and disclosure requirements, leading to reduced transparency.
- Increased volatility due to smaller market capitalization and limited institutional interest.
- Greater susceptibility to market manipulation due to less regulatory oversight.
- Difficulty in obtaining reliable and timely financial information for due diligence.
- Verify the company's financial reports and disclosures directly from its home country (Australia) regulatory bodies.
- Research the company's business operations, management team, and competitive landscape thoroughly.
- Assess the trading volume and bid-ask spread to understand potential liquidity challenges.
- Examine the company's corporate governance practices and shareholder rights.
- Understand the specific risks associated with Level 1 ADRs and OTC Other tier trading.
- Consult independent financial news and research sources for any available information.
- Evaluate the company's long-term growth prospects and financial health independent of its OTC listing.
- Ansell Limited is a well-established company founded in 1893 with a long operating history.
- It has a significant market capitalization of $2.89B, indicating a substantial business.
- The company operates globally across multiple continents, suggesting a legitimate and widespread business.
- It is headquartered in Richmond, Australia, and its home market ticker is ANSL, implying a primary listing on a regulated exchange (ASX).
- The company has a clear business description and operates in essential sectors (Healthcare, Industrial).
What Investors Ask About Ansell Limited (ANSLY) — Healthcare
What does Ansell Limited do?
Ansell Limited is a global leader in designing, developing, and manufacturing protection solutions. The company operates through two main segments: Healthcare and Industrial. In the Healthcare segment, Ansell produces surgical gloves, single-use and examination gloves, and clean/sterile garments for hospitals, dental practices, laboratories, and life sciences companies. The Industrial segment focuses on hand and chemical protective clothing for various industries like automotive, chemical, mining, and food processing. Founded in 1893, Ansell leverages its extensive product portfolio and global reach across Asia Pacific, Europe, the Middle East, Africa, Latin America, and North America to provide essential safety and protection equipment.
How does Ansell Limited manage raw material costs and supply chain risks?
Ansell Limited, like many manufacturers in the protection solutions industry, is exposed to fluctuations in raw material costs, particularly for polymers and chemicals essential for glove and protective clothing production. The company likely employs strategies such as long-term supply contracts, hedging instruments, and diversification of suppliers to mitigate these risks. Effective supply chain management is crucial, involving careful inventory planning, logistics optimization, and establishing relationships with multiple vendors across different geographies. This multi-pronged approach aims to ensure a stable supply of materials, control input costs, and minimize disruptions from geopolitical events, natural disasters, or trade barriers, thereby safeguarding profitability and operational continuity.
What are the main risks for ANSLY?
Investing in ANSLY carries several key risks. Fluctuations in raw material costs, such as for latex and synthetic polymers, can directly impact Ansell's profit margins. The company faces ongoing intense competition from both large multinational corporations and smaller regional players in the global PPE market. As an ADR, ANSLY is exposed to currency risk, where changes in the AUD/USD exchange rate can affect the value of the investment and dividends. Global economic downturns or industry-specific slowdowns could reduce demand for both industrial safety products and healthcare consumables. Additionally, as an OTC-traded stock, ANSLY may experience lower liquidity and less stringent disclosure requirements compared to major exchange-listed companies.
How does Ansell Limited's global presence impact its operations and market diversification?
Ansell Limited's extensive global presence, spanning Asia Pacific, Europe, the Middle East, Africa, Latin America, and North America, significantly impacts its operations and market diversification. This broad geographic reach allows the company to tap into diverse economic cycles and regulatory environments, reducing over-reliance on any single market. It provides access to a wider customer base and enables the company to adapt products to specific regional needs and standards. However, it also introduces complexities such as managing varied regulatory compliance, navigating different cultural business practices, and mitigating currency exchange rate risks across multiple jurisdictions. The diversification helps stabilize revenue streams but requires robust international management capabilities.
What are the key factors to evaluate for ANSLY?
Ansell Limited (ANSLY) holds an AI score of 56/100 (moderate). P/E: 20.8x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does ANSLY data refresh on this page?
ANSLY prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven ANSLY's recent stock price performance?
Ansell Limited (ANSLY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Long-standing global brand reputation and market leadership in protection solutions. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ANSLY overvalued or undervalued right now?
Ansell Limited (ANSLY) trades at 20.8x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- CEO background and track record could not be detailed due to lack of specific information in the provided source data, adhering to the 'ONLY use facts from the provided source' rule.
- Word count for CEO profile sub-fields (background, trackRecord) could not be met due to lack of source data, as per the 'output Unknown' rule.